Tetrahydropyranyladriamycin with FK 506 combination therapy for hamster-to-rat-concordant xenotransplantation.
Namii
Y
Y
Department of Surgery, Nagoya University School of Medicine, Japan.
Yasutomi
M
M
Hayashi
S
S
Ito
M
M
Ohtsuka
S
S
Uchida
K
K
Yokoyama
I
I
Takagi
H
H
D000818:Animals; D000910:Antibodies, Heterophile / Q000097:blood; D006224:Cricetinae; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000097:blood / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology*; D007075:Immunoglobulin M / Q000097:blood; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008647:Mesocricetus; D051381:Rats; D017208:Rats, Wistar; D016559:Tacrolimus / Q000627:therapeutic use*; D014183:Transplantation, Heterologous / Q000276:immunology*
D000910:Antibodies, Heterophile; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D004317:Doxorubicin; C027260:pirarubicin; D016559:Tacrolimus